A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
NCT07083206 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4500
Last updated 2025-08-07
Summary
The objective of this study is to evaluate the effectiveness and safety of Pitavastatin/Ezetimibe FDC in patients with hypercholesterolemia.
Conditions
- Hypercholesterolemia
- Dyslipidemias
Sponsors & Collaborators
-
Ahn-Gook Pharmaceuticals Co.,Ltd
lead INDUSTRY
Principal Investigators
-
Deok Kyu Cho · Severance Hospital
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-29
- Primary Completion
- 2028-07-31
- Completion
- 2029-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
NCT00249249 ·Status: COMPLETED ·Phase: PHASE3
-
To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients
NCT06866509 ·Status: COMPLETED
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
NCT01370590 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
NCT01370603 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
NCT05761444 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia
NCT05206578 ·Status: UNKNOWN ·Phase: PHASE3
-
Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)
NCT00166504 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)
NCT00202904 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia
NCT01166633 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
NCT00309751 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
NCT02451098 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe-Rosuvastatin Evaluation Study
NCT03947866 ·Status: UNKNOWN
-
Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)
NCT00705081 ·Status: COMPLETED
-
Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT04643093 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
NCT00257686 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
NCT05930028 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)
NCT00157924 ·Status: COMPLETED ·Phase: PHASE4
-
Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
NCT03434613 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
NCT00535405 ·Status: COMPLETED ·Phase: PHASE3
-
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
NCT00344370 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)
NCT00651014 ·Status: TERMINATED ·Phase: PHASE4
-
Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)
NCT00651404 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
NCT00276458 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
NCT00309777 ·Status: COMPLETED ·Phase: PHASE3
-
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
NCT01256476 ·Status: COMPLETED ·Phase: PHASE4